VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q57025647 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010725.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q57025647‏
024 ‎‡a 0000-0002-7794-7265‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q57025647‏
100 0 ‎‡a Michael G Schmidt‏ ‎‡9 es‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a মাইকেল জি শ্মিট‏ ‎‡9 bn‏
400 0 ‎‡a Michael G Schmidt‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Michael G Schmidt‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's Anti-endotoxin monoclonal antibodies are protective against hepatic ischemia/reperfusion injury in steatotic mice‏
670 ‎‡a Author's Antimicrobial copper alloys decreased bacteria on stethoscope surfaces.‏
670 ‎‡a Author's Antimicrobial surfaces to prevent healthcare-associated infections: a systematic review: a different view‏
670 ‎‡a Author's Biodegradation of BTEX vapors in a silicone membrane bioreactor system‏
670 ‎‡a Author's Cerulenin blockade of fatty acid synthase reverses hepatic steatosis in ob/ob mice‏
670 ‎‡a Author's Characterization and control of the microbial community affiliated with copper or aluminum heat exchangers of HVAC systems.‏
670 ‎‡a Author's Comparative denaturing gradient gel electrophoresis analysis of fungal communities associated with whole plant corn silage‏
670 ‎‡a Author's Comparison of microporous and nonporous membrane bioreactor systems for the treatment of BTEX in vapor streams‏
670 ‎‡a Author's Control and mitigation of healthcare-acquired infections: designing clinical trials to evaluate new materials and technologies‏
670 ‎‡a Author's Copper alloy surfaces sustain terminal cleaning levels in a rural hospital.‏
670 ‎‡a Author's Copper continuously limits the concentration of bacteria resident on bed rails within the intensive care unit‏
670 ‎‡a Author's Copper surfaces are associated with significantly lower concentrations of bacteria on selected surfaces within a pediatric intensive care unit.‏
670 ‎‡a Author's Copper surfaces in the ICU reduced the relative risk of acquiring an infection while hospitalized‏
670 ‎‡a Author's Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit.‏
670 ‎‡a Author's Decrease of intracellular ATP content downregulated UCP2 expression in mouse hepatocytes‏
670 ‎‡a Author's Development of a P1 phagemid system for the delivery of DNA into Gram-negative bacteria‏
670 ‎‡a Author's Development of a thermally regulated broad-spectrum promoter system for use in pathogenic gram-positive species‏
670 ‎‡a Author's Development of an unbiased method for the estimation of liver steatosis‏
670 ‎‡a Author's Direct-rapid (DR) mutagenesis of large plasmids using PCR.‏
670 ‎‡a Author's Doc-mediated cell killing in Shigella flexneri using a C1/LacI controlled expression system‏
670 ‎‡a Author's Evaluation of the antimicrobial properties of copper surfaces in an outpatient infectious disease practice‏
670 ‎‡a Author's Fatty acid synthase blockade protects steatotic livers from warm ischemia reperfusion injury and transplantation.‏
670 ‎‡a Author's From Laboratory Research to a Clinical Trial: Copper Alloy Surfaces Kill Bacteria and Reduce Hospital-Acquired Infections.‏
670 ‎‡a Author's Glutathione overproduction by selenite-resistant Escherichia coli.‏
670 ‎‡a Author's Hepatocellular ultrastructure after ischemia/reperfusion injury in human orthotopic liver transplantation‏
670 ‎‡a Author's Identification of export proteins from Mycobacterium tuberculosis that interact with SecA.‏
670 ‎‡a Author's In situ evaluation of a persistent disinfectant provides continuous decontamination within the clinical environment‏
670 ‎‡a Author's Intereukin-10 and Kupffer cells protect steatotic mice livers from ischemia-reperfusion injury.‏
670 ‎‡a Author's Intrinsic bacterial burden associated with intensive care unit hospital beds: effects of disinfection on population recovery and mitigation of potential infection risk‏
670 ‎‡a Author's Mitochondrial uncoupling protein-2 deficiency protects steatotic mouse hepatocytes from hypoxia/reoxygenation‏
670 ‎‡a Author's Mitochondrial uncoupling protein 2 induces cell cycle arrest and necrotic cell death‏
670 ‎‡a Author's Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion.‏
670 ‎‡a Author's Murine Kupffer cells are protective in total hepatic ischemia/reperfusion injury with bowel congestion through IL-10.‏
670 ‎‡a Author's Nucleotide sequence of the secA gene and secA(Ts) mutations preventing protein export in Escherichia coli.‏
670 ‎‡a Author's Overcoming the phage replication threshold: a mathematical model with implications for phage therapy‏
670 ‎‡a Author's Patient environment microbial burden reduction: a pilot study comparison of 2 terminal cleaning methods‏
670 ‎‡a Author's Perspectives from the field in response to "It is time to revise our approach to registering antimicrobial agents for health care settings".‏
670 ‎‡a Author's Potential effectiveness of copper surfaces in reducing health care-associated infection rates in a pediatric intensive and intermediate care unit: A nonrandomized controlled trial‏
670 ‎‡a Author's Rapid purification of native SecA from Escherichia coli: development of a new affinity chromatography procedure‏
670 ‎‡a Author's Regulation of Escherichia coli secA mRNA translation by a secretion-responsive element.‏
670 ‎‡a Author's Regulation of the Escherichia coli secA gene is mediated by two distinct RNA structural conformations‏
670 ‎‡a Author's Reply to Harbarth et al.‏
670 ‎‡a Author's SecA: the ubiquitous component of preprotein translocase in prokaryotes.‏
670 ‎‡a Author's Self-Disinfecting Copper Beds Sustain Terminal Cleaning and Disinfection Effects throughout Patient Care‏
670 ‎‡a Author's Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.‏
670 ‎‡a Author's Steatotic liver transplantation in the mouse: a model of primary nonfunction‏
670 ‎‡a Author's Sustained reduction of microbial burden on common hospital surfaces through introduction of copper.‏
670 ‎‡a Author's Tandem biodegradation of BTEX components by two Pseudomonas sp.‏
670 ‎‡a Author's The use of the Papworth cocktail is detrimental to steatotic livers after ischemia-reperfusion injury‏
670 ‎‡a Author's Tight regulation and modulation via a C1-regulated promoter in Escherichia coli and Pseudomonas aeruginosa.‏
670 ‎‡a Author's Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury‏
670 ‎‡a Author's Toll-like receptor 4 knockout mice are protected from endothelial overactivation in the absence of Kupffer cells after total hepatic ischemia/reperfusion.‏
670 ‎‡a Author's Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.‏
670 ‎‡a Author's Vitamin E succinate enhances steatotic liver energy status and prevents oxidative damage following ischemia/reperfusion‏
670 ‎‡a Author's Vitamin E succinate reduces ischemia/reperfusion injury in steatotic livers.‏
909 ‎‡a (orcid) 0000000277947265‏ ‎‡9 1‏
919 ‎‡a tightregulationandmodulationviaac1regulatedpromoterinescherichiacoliandpseudomonasaeruginosa‏ ‎‡A Tight regulation and modulation via a C1-regulated promoter in Escherichia coli and Pseudomonas aeruginosa.‏ ‎‡9 1‏
919 ‎‡a useofthepapworthcocktailisdetrimentaltosteatoticliversafterischemiareperfusioninjury‏ ‎‡A The use of the Papworth cocktail is detrimental to steatotic livers after ischemia-reperfusion injury‏ ‎‡9 1‏
919 ‎‡a tandembiodegradationofbtexcomponentsby2pseudomonassp‏ ‎‡A Tandem biodegradation of BTEX components by two Pseudomonas sp.‏ ‎‡9 1‏
919 ‎‡a sustainedreductionofmicrobialburdenoncommonhospitalsurfacesthroughintroductionofcopper‏ ‎‡A Sustained reduction of microbial burden on common hospital surfaces through introduction of copper.‏ ‎‡9 1‏
919 ‎‡a steatoticlivertransplantationinthemouseamodelofprimarynonfunction‏ ‎‡A Steatotic liver transplantation in the mouse: a model of primary nonfunction‏ ‎‡9 1‏
919 ‎‡a shorttermadministrationofepigallocatechingallatereduceshepaticsteatosisandprotectsagainstwarmhepaticischemiareperfusioninjuryinsteatoticmice‏ ‎‡A Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.‏ ‎‡9 1‏
919 ‎‡a selfdisinfectingcopperbedssustainterminalcleaninganddisinfectioneffectsthroughoutpatientcare‏ ‎‡A Self-Disinfecting Copper Beds Sustain Terminal Cleaning and Disinfection Effects throughout Patient Care‏ ‎‡9 1‏
919 ‎‡a secatheubiquitouscomponentofpreproteintranslocaseinprokaryotes‏ ‎‡A SecA: the ubiquitous component of preprotein translocase in prokaryotes.‏ ‎‡9 1‏
919 ‎‡a replytoharbarthetal‏ ‎‡A Reply to Harbarth et al.‏ ‎‡9 1‏
919 ‎‡a regulationoftheescherichiacolisecageneismediatedby2distinctrnastructuralconformations‏ ‎‡A Regulation of the Escherichia coli secA gene is mediated by two distinct RNA structural conformations‏ ‎‡9 1‏
919 ‎‡a regulationofescherichiacolisecamrnatranslationbyasecretionresponsiveelement‏ ‎‡A Regulation of Escherichia coli secA mRNA translation by a secretion-responsive element.‏ ‎‡9 1‏
919 ‎‡a rapidpurificationofnativesecafromescherichiacolidevelopmentofanewaffinitychromatographyprocedure‏ ‎‡A Rapid purification of native SecA from Escherichia coli: development of a new affinity chromatography procedure‏ ‎‡9 1‏
919 ‎‡a potentialeffectivenessofcoppersurfacesinreducinghealthcareassociatedinfectionratesinapediatricintensiveandintermediatecareunitanonrandomizedcontrolledtrial‏ ‎‡A Potential effectiveness of copper surfaces in reducing health care-associated infection rates in a pediatric intensive and intermediate care unit: A nonrandomized controlled trial‏ ‎‡9 1‏
919 ‎‡a perspectivesfromthefieldinresponsetoitistimetoreviseourapproachtoregisteringantimicrobialagentsforhealthcaresettings‏ ‎‡A Perspectives from the field in response to "It is time to revise our approach to registering antimicrobial agents for health care settings".‏ ‎‡9 1‏
919 ‎‡a patientenvironmentmicrobialburdenreductionapilotstudycomparisonof2terminalcleaningmethods‏ ‎‡A Patient environment microbial burden reduction: a pilot study comparison of 2 terminal cleaning methods‏ ‎‡9 1‏
919 ‎‡a overcomingthephagereplicationthresholdamathematicalmodelwithimplicationsforphagetherapy‏ ‎‡A Overcoming the phage replication threshold: a mathematical model with implications for phage therapy‏ ‎‡9 1‏
919 ‎‡a nucleotidesequenceofthesecageneandsecatsmutationspreventingproteinexportinescherichiacoli‏ ‎‡A Nucleotide sequence of the secA gene and secA(Ts) mutations preventing protein export in Escherichia coli.‏ ‎‡9 1‏
919 ‎‡a murinekupffercellsareprotectiveintotalhepaticischemiareperfusioninjurywithbowelcongestionthroughil10‏ ‎‡A Murine Kupffer cells are protective in total hepatic ischemia/reperfusion injury with bowel congestion through IL-10.‏ ‎‡9 1‏
919 ‎‡a mitochondrialuncouplingprotein2mediatessteatoticliverinjuryfollowingischemiareperfusion‏ ‎‡A Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion.‏ ‎‡9 1‏
919 ‎‡a mitochondrialuncouplingprotein2inducescellcyclearrestandnecroticcelldeath‏ ‎‡A Mitochondrial uncoupling protein 2 induces cell cycle arrest and necrotic cell death‏ ‎‡9 1‏
919 ‎‡a mitochondrialuncouplingprotein2deficiencyprotectssteatoticmousehepatocytesfromhypoxiareoxygenation‏ ‎‡A Mitochondrial uncoupling protein-2 deficiency protects steatotic mouse hepatocytes from hypoxia/reoxygenation‏ ‎‡9 1‏
919 ‎‡a intrinsicbacterialburdenassociatedwithintensivecareunithospitalbedseffectsofdisinfectiononpopulationrecoveryandmitigationofpotentialinfectionrisk‏ ‎‡A Intrinsic bacterial burden associated with intensive care unit hospital beds: effects of disinfection on population recovery and mitigation of potential infection risk‏ ‎‡9 1‏
919 ‎‡a intereukin10andkupffercellsprotectsteatoticmiceliversfromischemiareperfusioninjury‏ ‎‡A Intereukin-10 and Kupffer cells protect steatotic mice livers from ischemia-reperfusion injury.‏ ‎‡9 1‏
919 ‎‡a insituevaluationofapersistentdisinfectantprovidescontinuousdecontaminationwithintheclinicalenvironment‏ ‎‡A In situ evaluation of a persistent disinfectant provides continuous decontamination within the clinical environment‏ ‎‡9 1‏
919 ‎‡a identificationofexportproteinsfrommycobacteriumtuberculosisthatinteractwithseca‏ ‎‡A Identification of export proteins from Mycobacterium tuberculosis that interact with SecA.‏ ‎‡9 1‏
919 ‎‡a hepatocellularultrastructureafterischemiareperfusioninjuryinhumanorthotopiclivertransplantation‏ ‎‡A Hepatocellular ultrastructure after ischemia/reperfusion injury in human orthotopic liver transplantation‏ ‎‡9 1‏
919 ‎‡a glutathioneoverproductionbyseleniteresistantescherichiacoli‏ ‎‡A Glutathione overproduction by selenite-resistant Escherichia coli.‏ ‎‡9 1‏
919 ‎‡a fromlaboratoryresearchtoaclinicaltrialcopperalloysurfaceskillbacteriaandreducehospitalacquiredinfections‏ ‎‡A From Laboratory Research to a Clinical Trial: Copper Alloy Surfaces Kill Bacteria and Reduce Hospital-Acquired Infections.‏ ‎‡9 1‏
919 ‎‡a fattyacidsynthaseblockadeprotectssteatoticliversfromwarmischemiareperfusioninjuryandtransplantation‏ ‎‡A Fatty acid synthase blockade protects steatotic livers from warm ischemia reperfusion injury and transplantation.‏ ‎‡9 1‏
919 ‎‡a evaluationoftheantimicrobialpropertiesofcoppersurfacesinanoutpatientinfectiousdiseasepractice‏ ‎‡A Evaluation of the antimicrobial properties of copper surfaces in an outpatient infectious disease practice‏ ‎‡9 1‏
919 ‎‡a docmediatedcellkillinginshigellaflexneriusingac1lacicontrolledexpressionsystem‏ ‎‡A Doc-mediated cell killing in Shigella flexneri using a C1/LacI controlled expression system‏ ‎‡9 1‏
919 ‎‡a directrapiddrmutagenesisoflargeplasmidsusingpcr‏ ‎‡A Direct-rapid (DR) mutagenesis of large plasmids using PCR.‏ ‎‡9 1‏
919 ‎‡a developmentofanunbiasedmethodfortheestimationofliversteatosis‏ ‎‡A Development of an unbiased method for the estimation of liver steatosis‏ ‎‡9 1‏
919 ‎‡a developmentofathermallyregulatedbroadspectrumpromotersystemforuseinpathogenicgrampositivespecies‏ ‎‡A Development of a thermally regulated broad-spectrum promoter system for use in pathogenic gram-positive species‏ ‎‡9 1‏
919 ‎‡a developmentofap1phagemidsystemforthedeliveryofdnaintogramnegativebacteria‏ ‎‡A Development of a P1 phagemid system for the delivery of DNA into Gram-negative bacteria‏ ‎‡9 1‏
919 ‎‡a decreaseofintracellularatpcontentdownregulateducp2expressioninmousehepatocytes‏ ‎‡A Decrease of intracellular ATP content downregulated UCP2 expression in mouse hepatocytes‏ ‎‡9 1‏
919 ‎‡a coppersurfacesreducetherateofhealthcareacquiredinfectionsintheintensivecareunit‏ ‎‡A Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit.‏ ‎‡9 1‏
919 ‎‡a coppersurfacesintheicureducedtherelativeriskofacquiringaninfectionwhilehospitalized‏ ‎‡A Copper surfaces in the ICU reduced the relative risk of acquiring an infection while hospitalized‏ ‎‡9 1‏
919 ‎‡a coppersurfacesareassociatedwithsignificantlylowerconcentrationsofbacteriaonselectedsurfaceswithinapediatricintensivecareunit‏ ‎‡A Copper surfaces are associated with significantly lower concentrations of bacteria on selected surfaces within a pediatric intensive care unit.‏ ‎‡9 1‏
919 ‎‡a coppercontinuouslylimitstheconcentrationofbacteriaresidentonbedrailswithintheintensivecareunit‏ ‎‡A Copper continuously limits the concentration of bacteria resident on bed rails within the intensive care unit‏ ‎‡9 1‏
919 ‎‡a copperalloysurfacessustainterminalcleaninglevelsinaruralhospital‏ ‎‡A Copper alloy surfaces sustain terminal cleaning levels in a rural hospital.‏ ‎‡9 1‏
919 ‎‡a controlandmitigationofhealthcareacquiredinfectionsdesigningclinicaltrialstoevaluatenewmaterialsandtechnologies‏ ‎‡A Control and mitigation of healthcare-acquired infections: designing clinical trials to evaluate new materials and technologies‏ ‎‡9 1‏
919 ‎‡a comparisonofmicroporousandnonporousmembranebioreactorsystemsforthetreatmentofbtexinvaporstreams‏ ‎‡A Comparison of microporous and nonporous membrane bioreactor systems for the treatment of BTEX in vapor streams‏ ‎‡9 1‏
919 ‎‡a comparativedenaturinggradientgelelectrophoresisanalysisoffungalcommunitiesassociatedwithwholeplantcornsilage‏ ‎‡A Comparative denaturing gradient gel electrophoresis analysis of fungal communities associated with whole plant corn silage‏ ‎‡9 1‏
919 ‎‡a characterizationandcontrolofthemicrobialcommunityaffiliatedwithcopperoraluminumheatexchangersofhvacsystems‏ ‎‡A Characterization and control of the microbial community affiliated with copper or aluminum heat exchangers of HVAC systems.‏ ‎‡9 1‏
919 ‎‡a ceruleninblockadeoffattyacidsynthasereverseshepaticsteatosisinobobmice‏ ‎‡A Cerulenin blockade of fatty acid synthase reverses hepatic steatosis in ob/ob mice‏ ‎‡9 1‏
919 ‎‡a biodegradationofbtexvaporsinasiliconemembranebioreactorsystem‏ ‎‡A Biodegradation of BTEX vapors in a silicone membrane bioreactor system‏ ‎‡9 1‏
919 ‎‡a antimicrobialsurfacestopreventhealthcareassociatedinfectionsasystematicreviewadifferentview‏ ‎‡A Antimicrobial surfaces to prevent healthcare-associated infections: a systematic review: a different view‏ ‎‡9 1‏
919 ‎‡a antimicrobialcopperalloysdecreasedbacteriaonstethoscopesurfaces‏ ‎‡A Antimicrobial copper alloys decreased bacteria on stethoscope surfaces.‏ ‎‡9 1‏
919 ‎‡a antiendotoxinmonoclonalantibodiesareprotectiveagainsthepaticischemiareperfusioninjuryinsteatoticmice‏ ‎‡A Anti-endotoxin monoclonal antibodies are protective against hepatic ischemia/reperfusion injury in steatotic mice‏ ‎‡9 1‏
919 ‎‡a vitaminesuccinatereducesischemiareperfusioninjuryinsteatoticlivers‏ ‎‡A Vitamin E succinate reduces ischemia/reperfusion injury in steatotic livers.‏ ‎‡9 1‏
919 ‎‡a vitaminesuccinateenhancessteatoticliverenergystatusandpreventsoxidativedamagefollowingischemiareperfusion‏ ‎‡A Vitamin E succinate enhances steatotic liver energy status and prevents oxidative damage following ischemia/reperfusion‏ ‎‡9 1‏
919 ‎‡a useofgeneticallyengineeredphagetodeliverantimicrobialagentstobacteriaanalternativetherapyfortreatmentofbacterialinfections‏ ‎‡A Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.‏ ‎‡9 1‏
919 ‎‡a tolllikereceptor4knockoutmiceareprotectedfromendothelialoveractivationintheabsenceofkupffercellsaftertotalhepaticischemiareperfusion‏ ‎‡A Toll-like receptor 4 knockout mice are protected from endothelial overactivation in the absence of Kupffer cells after total hepatic ischemia/reperfusion.‏ ‎‡9 1‏
919 ‎‡a tolllikereceptor4isakeymediatorofmurinesteatoticliverwarmischemiareperfusioninjury‏ ‎‡A Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 LC|n 95003959‏
996 ‎‡2 ISNI|0000000109003791‏
996 ‎‡2 SIMACOB|116169059‏
996 ‎‡2 ISNI|0000000458751288‏
996 ‎‡2 DNB|1037531019‏
996 ‎‡2 DNB|173517129‏
996 ‎‡2 DE633|pe41010321‏
996 ‎‡2 DNB|1023671360‏
996 ‎‡2 ISNI|0000000387350435‏
996 ‎‡2 LC|n 2001046224‏
996 ‎‡2 DNB|1052471102‏
996 ‎‡2 NUKAT|n 2013152927‏
996 ‎‡2 LC|no2014076345‏
996 ‎‡2 NTA|071639829‏
996 ‎‡2 DNB|114702345X‏
996 ‎‡2 ISNI|0000000075486392‏
996 ‎‡2 DNB|130603619‏
996 ‎‡2 DNB|1061460959‏
996 ‎‡2 ISNI|0000000382396979‏
996 ‎‡2 DNB|1023032112‏
996 ‎‡2 BIBSYS|90813312‏
996 ‎‡2 LC|no2001083639‏
996 ‎‡2 BIBSYS|1035019‏
996 ‎‡2 ISNI|000000009114646X‏
996 ‎‡2 SUDOC|035698314‏
996 ‎‡2 PLWABN|9810692475105606‏
996 ‎‡2 VLACC|000025275‏
996 ‎‡2 DBC|87097948120466‏
996 ‎‡2 RERO|A011368326‏
996 ‎‡2 SUDOC|158233360‏
996 ‎‡2 NTA|074034669‏
996 ‎‡2 DNB|1116302349‏
996 ‎‡2 DNB|1319139213‏
996 ‎‡2 DNB|1073495647‏
996 ‎‡2 DNB|137234945‏
996 ‎‡2 BNF|13330418‏
996 ‎‡2 SUDOC|032030525‏
996 ‎‡2 BNF|16695903‏
996 ‎‡2 PLWABN|9810674642005606‏
996 ‎‡2 DNB|1155485106‏
996 ‎‡2 ISNI|0000000049723892‏
996 ‎‡2 BNF|14605236‏
996 ‎‡2 LC|no2014059061‏
996 ‎‡2 NTA|113129351‏
996 ‎‡2 PLWABN|9810686145705606‏
996 ‎‡2 LC|n 93090931‏
996 ‎‡2 SZ|1026730015‏
996 ‎‡2 BNF|17097121‏
996 ‎‡2 SUDOC|099361450‏
996 ‎‡2 ISNI|0000000072256401‏
996 ‎‡2 DNB|1205345191‏
996 ‎‡2 NUKAT|n 2015137330‏
996 ‎‡2 NKC|pna2017943300‏
996 ‎‡2 NII|DA17734971‏
996 ‎‡2 RERO|A012459084‏
996 ‎‡2 DBC|87097968913799‏
996 ‎‡2 J9U|987007279396505171‏
996 ‎‡2 BLBNB|000236002‏
996 ‎‡2 J9U|987007426826605171‏
996 ‎‡2 DNB|133946274‏
996 ‎‡2 DNB|121121798‏
996 ‎‡2 RERO|A012457201‏
996 ‎‡2 BNF|18177218‏
996 ‎‡2 NTA|325569657‏
996 ‎‡2 CAOONL|ncf11490562‏
996 ‎‡2 LC|n 83165579‏
996 ‎‡2 ISNI|0000000400196437‏
996 ‎‡2 PLWABN|9811513549605606‏
996 ‎‡2 BNF|18008084‏
996 ‎‡2 DNB|1225894603‏
996 ‎‡2 DNB|112329044X‏
996 ‎‡2 NTA|155269712‏
996 ‎‡2 BIBSYS|13037104‏
996 ‎‡2 ISNI|0000000028661274‏
996 ‎‡2 J9U|987007601221605171‏
996 ‎‡2 BIBSYS|15022725‏
996 ‎‡2 DNB|1049616006‏
996 ‎‡2 DNB|1157188451‏
996 ‎‡2 CAOONL|ncf11259843‏
996 ‎‡2 ISNI|0000000072498558‏
996 ‎‡2 DNB|1033074349‏
996 ‎‡2 PLWABN|9813204294505606‏
996 ‎‡2 SIMACOB|206685795‏
996 ‎‡2 BNF|16631377‏
996 ‎‡2 SUDOC|110059247‏
996 ‎‡2 J9U|987007320790805171‏
996 ‎‡2 DNB|1195095821‏
996 ‎‡2 NUKAT|n 2014048869‏
996 ‎‡2 LC|no2015146964‏
996 ‎‡2 DNB|120166348‏
996 ‎‡2 N6I|vtls000073620‏
996 ‎‡2 DNB|1035821753‏
996 ‎‡2 ISNI|0000000453079736‏
996 ‎‡2 DE633|pe179756‏
996 ‎‡2 ISNI|0000000019517836‏
996 ‎‡2 ISNI|0000000035663147‏
996 ‎‡2 DNB|1032633190‏
996 ‎‡2 DNB|130956244‏
996 ‎‡2 DNB|173866646‏
996 ‎‡2 ISNI|0000000068723601‏
996 ‎‡2 DNB|134124235‏
996 ‎‡2 NTA|326504664‏
996 ‎‡2 BNF|17143321‏
996 ‎‡2 ISNI|0000000367710464‏
996 ‎‡2 NUKAT|n 2012211022‏
996 ‎‡2 DNB|1020336943‏
996 ‎‡2 W2Z|1542227323045‏
996 ‎‡2 DNB|111647316X‏
996 ‎‡2 DNB|143624636‏
996 ‎‡2 ISNI|0000000407958369‏
996 ‎‡2 DNB|120369370‏
996 ‎‡2 BNF|12688931‏
996 ‎‡2 LC|n 2004051457‏
996 ‎‡2 DNB|1096250853‏
996 ‎‡2 NLA|000036022058‏
996 ‎‡2 DNB|1111665117‏
996 ‎‡2 DNB|1217732179‏
996 ‎‡2 NUKAT|n 2008110519‏
996 ‎‡2 NTA|204367751‏
996 ‎‡2 DBC|87097919324664‏
996 ‎‡2 DNB|1241795606‏
996 ‎‡2 PLWABN|9813197498305606‏
996 ‎‡2 CAOONL|ncf11003454‏
996 ‎‡2 LC|no2019106485‏
996 ‎‡2 NUKAT|n 01046376‏
996 ‎‡2 NII|DA18198597‏
996 ‎‡2 DNB|143072005‏
996 ‎‡2 DNB|1069122807‏
996 ‎‡2 ISNI|0000000023163495‏
996 ‎‡2 DNB|115584218‏
996 ‎‡2 DNB|128944021‏
996 ‎‡2 NUKAT|n 2017059758‏
996 ‎‡2 NII|DA03690007‏
996 ‎‡2 ISNI|0000000117148261‏
996 ‎‡2 DNB|129432547‏
996 ‎‡2 DNB|118060457‏
996 ‎‡2 CAOONL|ncf11576376‏
996 ‎‡2 NDL|00909238‏
996 ‎‡2 NTA|181300265‏
996 ‎‡2 PTBNP|156876‏
996 ‎‡2 NDL|001232184‏
996 ‎‡2 DNB|137273487‏
996 ‎‡2 DNB|141471867‏
996 ‎‡2 DNB|1259983889‏
996 ‎‡2 DNB|1035820498‏
996 ‎‡2 NUKAT|n 2020210058‏
996 ‎‡2 DNB|172360463‏
996 ‎‡2 NUKAT|n 2004005322‏
996 ‎‡2 BIBSYS|1460961538667‏
996 ‎‡2 DNB|135896789‏
996 ‎‡2 LC|n 82250941‏
996 ‎‡2 SUDOC|242677959‏
996 ‎‡2 LC|no2005053513‏
996 ‎‡2 DNB|1335526773‏
996 ‎‡2 DNB|141964669‏
996 ‎‡2 LC|no2020102204‏
996 ‎‡2 LC|n 85249641‏
996 ‎‡2 BNF|15123164‏
996 ‎‡2 SZ|1153072173‏
996 ‎‡2 LC|n 88003060‏
996 ‎‡2 DNB|129373826‏
996 ‎‡2 DNB|1026730015‏
996 ‎‡2 LC|n 84189354‏
996 ‎‡2 ISNI|000000040998152X‏
996 ‎‡2 DNB|1035713934‏
996 ‎‡2 LC|no2015123222‏
996 ‎‡2 SUDOC|035017856‏
996 ‎‡2 DNB|1161675078‏
996 ‎‡2 DNB|129993379‏
996 ‎‡2 SZ|1153078368‏
996 ‎‡2 RERO|A003801352‏
996 ‎‡2 DNB|1053158106‏
996 ‎‡2 LC|n 2022181249‏
996 ‎‡2 ISNI|0000000488203493‏
996 ‎‡2 ISNI|0000000081762760‏
996 ‎‡2 SUDOC|195557387‏
996 ‎‡2 NTA|131104799‏
996 ‎‡2 RERO|A003801320‏
996 ‎‡2 NTA|314572503‏
996 ‎‡2 DNB|1219234222‏
996 ‎‡2 DNB|1262620716‏
996 ‎‡2 DNB|115734142X‏
996 ‎‡2 PLWABN|9813282220105606‏
996 ‎‡2 ISNI|0000000030793428‏
996 ‎‡2 LNB|LNC10-000042551‏
996 ‎‡2 SUDOC|276758161‏
996 ‎‡2 NUKAT|n 99041326‏
996 ‎‡2 SUDOC|140250174‏
996 ‎‡2 DNB|120630834‏
996 ‎‡2 LC|n 2004100562‏
996 ‎‡2 DNB|137208537‏
996 ‎‡2 SUDOC|190862033‏
996 ‎‡2 J9U|987008195679905171‏
996 ‎‡2 SUDOC|148059856‏
996 ‎‡2 DNB|1140501844‏
996 ‎‡2 ISNI|0000000409695814‏
996 ‎‡2 DE633|pe30041714‏
996 ‎‡2 ISNI|0000000434869580‏
996 ‎‡2 DNB|130603627‏
996 ‎‡2 LC|nb2016007426‏
996 ‎‡2 NTA|072576286‏
996 ‎‡2 SUDOC|199486077‏
996 ‎‡2 SUDOC|255385382‏
996 ‎‡2 RERO|A013281675‏
996 ‎‡2 NTA|113864426‏
996 ‎‡2 NTA|07304492X‏
996 ‎‡2 DNB|13214235X‏
996 ‎‡2 LC|n 2010003853‏
996 ‎‡2 ISNI|0000000022235346‏
996 ‎‡2 DNB|1060702983‏
996 ‎‡2 J9U|987007396111505171‏
996 ‎‡2 DNB|1265504369‏
996 ‎‡2 SZ|137200447‏
996 ‎‡2 LC|n 92800905‏
996 ‎‡2 NII|DA06653663‏
996 ‎‡2 LC|n 90674533‏
996 ‎‡2 ISNI|0000000382858029‏
996 ‎‡2 SZ|1035821753‏
996 ‎‡2 PLWABN|9810672214605606‏
996 ‎‡2 DNB|1011603438‏
996 ‎‡2 ISNI|0000000394064904‏
996 ‎‡2 DNB|1035783649‏
996 ‎‡2 DNB|116941009X‏
996 ‎‡2 DNB|1121133770‏
996 ‎‡2 DNB|120923971‏
996 ‎‡2 DNB|1030241589‏
996 ‎‡2 NKC|jx20071106012‏
996 ‎‡2 NII|DA12198903‏
996 ‎‡2 BIBSYS|3089830‏
996 ‎‡2 NUKAT|n 2008106772‏
996 ‎‡2 DNB|1284343448‏
996 ‎‡2 SZ|1035822121‏
996 ‎‡2 J9U|987007422498405171‏
996 ‎‡2 SUDOC|159141672‏
996 ‎‡2 DBC|87097968913802‏
996 ‎‡2 PLWABN|9810543975205606‏
996 ‎‡2 NTA|06869704X‏
996 ‎‡2 ISNI|0000000114426991‏
996 ‎‡2 DNB|1154391434‏
996 ‎‡2 SUDOC|248783750‏
996 ‎‡2 DNB|116019033X‏
996 ‎‡2 LC|n 2016033347‏
996 ‎‡2 BNF|14385553‏
996 ‎‡2 RERO|A012334871‏
996 ‎‡2 DNB|1155200128‏
996 ‎‡2 NKC|xx0145803‏
996 ‎‡2 ISNI|000000006872361X‏
996 ‎‡2 BIBSYS|90544117‏
996 ‎‡2 SUDOC|271381469‏
996 ‎‡2 NUKAT|n 02045965‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏
998 ‎‡a Schmidt, Michael Gerard‏ ‎‡2 NUKAT|n 2017001339‏ ‎‡3 exact title: (1.00, 'fromlaboratoryresearchtoaclinicaltrialcopperalloysurfaceskillbacteriaandreducehospitalacquiredinfections', 'fromlaboratoryresearchtoaclinicaltrialcopperalloysurfaceskillbacteriaandreducehospitalacquiredinfections')‏ ‎‡3 viafid‏